StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > SZLS news

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Nov 23, 2020 10:24am

107 Views

Post# 31951832

RE:RE:RE:RE:RE:RE:SZLS news

So if you don't want to read all that, it just means our shares and warrants are undervalue right now and the market will correct itself. And the posts here have been very accurate about the offering holding the price back.

Jonnyboy85 wrote: I think I can explain that, there is a investing theory called convergence, whereby a stock can't trade at two different prices simultaneously and the two prices will gravitate towards one another until they are back in harmony. It accomplishes this as arbitrage opportunities are taken advantage of by traders while the two separate prices attempt to reconcile themselves. Arbitrage just means buying or selling to make money off the convergence, the narrowing of the two prices.

Now because the offering is static and unchanging, our open market share price is the one that will continue to move up and down to stay close to the offering price because of the theory of convergence and arbitrage traders. Also a side note, I found in the prospectus that the shares are being valued at 0.73 and half warrants at 0.05, totalling 0.78, thats why the confusion about our price moving up to 0.78 and then back down around 0.73. Until the offering closes, the price shouldn't be more or less than 0.73, and anything below or above that is an arbitrage opportunity and buying will push the price back up to 0.73 or selling down to 0.73. Links and the fineprint quote from the prospectus below,

"Units sold hereunder at a price equal to the Offering Price (in respect of the Additional Units), at $0.73, in respect of the Additional Shares and at $0.05 per each one-half of one Additional Warrant (or $0.10, per Additional Warrant"

https://www.investopedia.com/terms/c/convergence.asp#:~:text=Convergence%20happens%20because%20the%20market,place%20at%20the%20same%20time.&text=If%20significant%20price%20differences%20did,for%20profits%20with%20zero%20risk.

https://www.investopedia.com/ask/answers/what-is-arbitrage/

Slimchange wrote: Every time stock starts rolling and pushes 77-78 it drops to 72. Stock should be sitting 85-90 cents no problem.